Other substances

Viomycin

A cyclic peptide antibiotic.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
2
 AI-suggested references
0
 Clinical trials

General information

Viomycin on PubChem

 

Structure image - Viomycin

C1[C@@H](N=C(N[C@H]1O)N)[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H](CCCN)N

Supporting references

Link Tested on Impact factor Notes Publication date
Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2
3CLpro Small molecule In silico Screening 		in silico 3.22

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Sep/10/2020

AI-suggested references

Link Publication date
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach.
Apr/06/2022
Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors.
Jan/19/2022
Export (.csv)